Florida Cancer Specialists Leads Value-Based Care Discussions at AVBCC Summit
Event summary
- Florida Cancer Specialists (FCS) leaders are presenting at the AVBCC 2026 Educational Summit on October 7, 2026.
- FCS generated $140M in Medicare savings under the Oncology Care Model (OCM), including $31.7M in a single six-month period in 2021.
- FCS conducts over 180 active clinical trials annually through its partnership with Sarah Cannon Research Institute.
- Kiana Mehring, FCS Senior Vice President, received AVBCC's 40 Under 40 Cancer Award in 2026.
The big picture
Florida Cancer Specialists is positioning itself as a leader in value-based cancer care, leveraging its success in the Oncology Care Model (OCM) to influence future policy and operational strategies. The AVBCC Summit provides a platform for FCS to share its insights on integrating technology and policy to improve cancer care delivery. With over 180 active clinical trials annually, FCS is at the forefront of translating research into practical patient care.
What we're watching
- Policy Impact
- How CMS's Oncology Care Model (OCM) and Enhancing Oncology Model (EOM) will shape future cancer care reimbursement.
- Technological Integration
- Whether tech-enabled workflows can optimize complex cancer treatments like bispecific therapy and CAR-T.
- Operational Efficiency
- The pace at which FCS can expand value-based care initiatives while maintaining high patient outcomes.
Related topics
